Diphenylpropane Derivatives as Agonist of PPAR Nuclear Receptors

摘要

This application claims derivatives of diphenylpropane as agonists of PPAR receptors for the treatment of a wide variety of diseases including metabolic, inflammatory, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.